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Coxiella burnetii, the agent of Q fever in humans and coxiellosis in other mammals, is an obligate intracel-
lular bacterium which is sheltered and multiplies within typically large phagolysosome-like replicative vacuoles
(LRVs). We have previously shown that, compared with fibroblasts, mouse resident peritoneal macrophages
control the development of LRVs and bacterial multiplication within these vacuoles. Earlier experiments with
the nitric oxide (NO) synthase inhibitor aminoguanidine (AG) revealed that the control is exerted by NO
induced by the bacteria. We report here that phagocytosis of apoptotic-like, but not of aldehyde-killed,
lymphocytes by the macrophages reduced the production of NO induced by the bacteria and increased the
development of LRVs and, therefore, the total bacterial load in the cultures. Experiments with macrophages
from mice deficient for inducible NO synthase (iNOS/) confirmed the involvement of NO in the control of
infection, since neither apoptotic lymphocytes nor AG affected the development of LRVs in these phagocytes.
Since macrophages are important for the clearance of apoptotic bodies and C. burnetii is able to induce
apoptosis in human monocytes, the phenomenon shown here may be biologically relevant to the development
of Q fever and coxiellosis.
The gram-negative, obligate intracellular bacterium Coxiella
burnetii, a member of the -subdivision of Proteobacteria, is the
agent of Q fever in humans, a zoonosis of nearly worldwide
distribution (2, 3, 19, 26, 27, 31). Once internalized by permis-
sive host cells, the bacteria are found in small phagosomes
which shelter a few organisms and fuse with each other and
with other endocytic or phagocytic vesicles. After two or more
days, most infected cells display one or more large replicative
vacuoles (LRVs), in which the bacterium multiplies (3, 4, 18,
19, 26, 33, 34).
These features describe the infection with virulent phase I or
nonvirulent phase II C. burnetii of primary or continuous cul-
tures of fibroblasts or epithelial, macrophage-like, or other cell
types susceptible to infection (1–3, 26, 29). In contrast, other
studies have suggested that human and mouse primary mac-
rophages are less permissive to infection (14, 15, 34, 35). Al-
though the mechanisms by which resistant host cells control C.
burnetii infection are not entirely understood, there is evidence
that tumor necrosis factor alpha and nitric oxide (NO) are
involved in the control of LRV formation and of bacterial
multiplication (5, 6, 14, 15, 35).
A variety of viral and nonviral pathogens have been shown
to kill macrophages or other host cells by a form of pro-
grammed cell death known as apoptosis (13). C. burnetii is no
exception, since it has also been shown to induce apoptosis in
infected human monocytes (6, 7).
Apoptotic cells are recognized and phagocytosed by profes-
sional and nonprofessional phagocytes; however, the clearance
is mainly made by macrophages (9, 10). It has been also shown
that interaction with apoptotic cells can enhance the secretion
of antiinflammatory factors, such as transforming growth fac-
tor  (TGF-), interleukin-10 (IL-10), and prostaglandin E2 by
macrophages (10, 20). However, whereas the induction of ap-
optosis by intracellular pathogens has been often examined,
few studies have addressed the effect of apoptotic cells on the
microbicidal activity of macrophages or other host cells. The
realization that antiinflammatory factors such as TGF-, IL-
10, or prostaglandin E2 also down-regulate the microbicidal
activity of macrophages has led to the pioneering demonstra-
tion that uptake of apoptotic lymphocytes by macrophages
increases the in vivo and in vitro susceptibility to infection of
mice with the trypanosomatid parasite Trypanosoma cruzi (11).
It was also proposed that phosphatidylserine expressed on
Leishmania parasites has a role in the recognition and intra-
cellular survival of the parasite in mouse macrophages (12).
Indeed, it has recently been shown that the uptake of apoptotic
cells by human immunodeficiency virus-infected primary mac-
rophages increases viral replication (25).
In this report, we have investigated if the uptake of apoptotic
cells enhances the infection of primary mouse macrophages by
the intracellular bacterial pathogen C. burnetii. Our results
show that cultures that have ingested apoptotic-like cells be-
come more susceptible to infection with C. burnetii phase II in
a process mediated by down-regulation of NO production by
macrophages.
MATERIALS AND METHODS
Macrophage culture. Primary macrophages were obtained from 7- to 9-week-
old C57BL/6 female mice. Animals that did not express the inducible nitric oxide
synthase (iNOS KO) were provided by Elaine Rodrigues (Universidade Federal
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de Sa˜o Paulo). Resident peritoneal macrophages (PM) were collected by wash-
outs of mouse peritoneal cavities as described previously (34). Cells (1.5  105),
attached to 13-mm-diameter glass coverslips, were placed in 2-cm2 wells of
24-well tissue culture plates and kept in 0.5 ml of antibiotic-free Dulbecco
modified essential medium containing 15 mM 4-(2-hydroxyethyl)-1-piperazine-
ethanesulfonic acid (HEPES), 2 g of sodium bicarbonate/liter, 1 mM L-glu-
tamine, and 5% (vol/vol) fetal bovine serum. Experiments were started 24 h after
preparation of the PM cultures.
Bone marrow-derived macrophages (BMM) were generated from bone mar-
row stem cells cultured on bacteriological plastic plates for 7 days in RPMI 1640
medium containing 15 mM HEPES, 2 g of sodium bicarbonate/liter, 1 mM
L-glutamine, and supplemented with 20% fetal bovine serum and 30% L929
cell-conditioned medium. Differentiated BMM were removed from the sub-
strate by vigorous pipetting of ice-cold phosphate-buffered saline. Cells were
seeded at 1.5 105 to glass coverslips inserted in 24-well tissue culture plates and
cultured in RPMI supplemented with 10% fetal bovine serum and 5% L929
cell-conditioned medium. All cultures were kept at 36°C in 5% CO2 in an air
atmosphere.
Lymphocyte preparation and apoptosis induction. Lymphocytes were purified
from C57BL/6 mouse spleens. The spleen was mechanically disrupted, and the
released cells were washed and treated with ACK buffer (150 mM NH4Cl, 10
mM KHCO3, 0.1 mM EDTA) for 10 min at room temperature to lyse red blood
cells. Splenocytes were washed and maintained in complete RPMI medium
supplemented with 10% fetal bovine serum. Apoptosis of the lymphocytes was
induced by heating at 56°C for 30 min (Apo-heat) or by gamma irradiation at
3,000 rads (30 Gy) (Apo-irrad) as previously described (11, 16). Lymphocytes
heated to 56°C were terminal deoxynucleotidyltransferase-mediated dUTP-bi-
otin nick end labeling positive and displayed nuclear fragmentation. However,
soon after heating these cells became permeable to propidium iodide, a charac-
teristic of necrotic cells. These features can be prevented by pretreatment of the
cells with the general caspase inhibitor z-VAD-FMC (M. F. Lopes, personal
communication). It is now clear that the features classically described as specific
for apoptotic cells may depend on the cell type and on the conditions that trigger
apoptosis. DNA fragmentation has been described in cells subjected to treat-
ments that are not associated with induction of apoptosis (28). For these reasons
we refer to these cells as apoptotic-like. Fixed splenocytes were obtained by
addition of 1% paraformaldehyde for 20 min at room temperature (followed by
extensive washing). Lysed cells were obtained by freezing at 20°C and thawing
at 37°C. Splenocyte suspensions were used at a multiplicity of infection of 3 cells
per macrophage. Aminoguanidine (AG; Sigma) was used at a 1 mM concentra-
tion. Macrophage cultures were treated with lymphocytes or AG, 24 h prior to C.
burnetii infection. The latter were maintained until the end of the experiment.
Phagocytic index and nitrite determination. To determine the phagocytic
index, macrophage cultures were fixed 3 h after addition of apoptotic or fixed
cells. 4,6-diamidino-2-phenylindole (DAPI) and an in situ cell death detection
kit (Roche) were used to stain the internalized fixed or apoptotic-like cells.
Between 300 and 500 macrophages per treatment were scored in four different
fields per coverslip to estimate the phagocytic index [percentage of macrophages
that phagocytosed splenocytes  (total number of internalized splenocytes/total
number of macrophages that phagocytosed splenocytes)].
The concentration of nitrite (NO2
 ), the stable oxidized derivative of NO, was
determined in 100-l aliquots of cell culture supernatants transferred to 96-well
plates. One hundred microliters of Griess reagent solution (1% sulfanilamide,
0.1% naphthylene diamine dihydrochloride, and 2% H3PO4) was added per well,
and absorbances were measured at 540 nm in a microplate enzyme-linked im-
munosorbent assay reader. Sodium nitrite diluted in culture medium was used as
a standard.
Bacterial preparation and infection of host cells. The clone 4 phase II Nine
Mile strain of C. burnetii, which is infective for cells but not for mammals, was
provided by Ted Hackstadt (Rocky Mountain Laboratories, National Institute of
Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Mont.)
and handled in a biosafety level II facility (17, 21). Infective inocula were
obtained as described previously (33) from confluent Vero cells infected with C.
burnetii for 7 days. Prior to infection, to disrupt aggregates, suspensions contain-
ing about 109 infective bacteria per ml were mildly sonicated at 35 kHz for 15 min
at room temperature. Macrophage cultures were infected with about 100 infec-
tive organisms per cell. After 24 h, infected cultures were vigorously washed with
Hanks saline, and the appropriate fresh medium was added.
Cell fixation, staining, and determination of the percentage of LRVs. At
different times after infection, cultures were fixed for 1 h in 3.5% formaldehyde
containing 7.5% sucrose, stained for 15 min with 3.5 M DAPI, washed, and
mounted in 50% glycerol (vol/vol). At least 350 cells in each of triplicate cover-
slips were scored with a 40 objective in an inverted microscope for the presence
or absence of large C. burnetii replicative vacuoles (LRVs).
Confocal microscopy, image acquisition, and determination of relative C.
burnetii load. Images were acquired in a Bio-Rad 1024UV confocal system
attached to a Zeiss Axiovert 100 microscope equipped with a 40 water immer-
sion objective, numerical aperture 1.2 plan-apochromatic lens and with differ-
ential interference contrast. LaserSharp 1024 version 2.1A from Bio-Rad was
used for image acquisition, and MetaMorph (version 3.5; Universal Imaging
Corporation) was used for image processing. Polygons were drawn onto digitized
images of infected cells, and the relative fluorescence intensity of DAPI-stained
bacteria within the circumscribed areas was determined. Under the measure-
ment conditions used, the fluorescence intensity within each polygon was as-
sumed to be proportional to the bacterial load in the region measured, as
previously described (33). Between 60 and 90 vacuoles were measured in each of
triplicate coverslips.
Bacterial viability. Infected macrophages were lysed in H2O, a step that did
not reduce the bacterial infectivity; lysates were sonicated, diluted, and used to
infect monolayers of Vero cells, previously irradiated (1,000 rads) to block cell
multiplication. Irradiated Vero cells were transferred to glass coverslips inserted
in the wells of 24-well tissue culture plates and cultured in minimal essential
medium supplemented with 5% fetal bovine serum at 37°C in a 5% CO2 atmo-
sphere. Four days after infection, Vero cells were washed with phosphate-buff-
ered saline, fixed, and stained with DAPI as described above. An epifluorescence
microscope equipped with a 40 objective was used to score the percentage of
infected cells. Dilutions chosen for counting contained in the range of 10 to 60%
infected cells. About 500 cells per coverslip were scored.
Statistical analysis. Each experiment was performed with triplicate sets of
wells. All tabulated or illustrated values are the averages of the triplicates from
one representative experiment out of two or more performed. Significant differ-
ences between means were determined by either Student’s t test or an analysis of
variance. Both tests were provided by the Microsoft Excel (version 97) statistics
package. Differences were taken as statistically significant when P was 	0.05.
RESULTS AND DISCUSSION
Uptake of apoptotic-like splenocytes increases the forma-
tion of C. burnetii LRVs in macrophages. Resident PM cul-
tures were incubated with suspensions of apoptotic-like
splenocytes (Apo-heat) or cells fixed with formaldehyde at a
multiplicity of three particles per macrophage. Splenocytes
heated to 56°C for 30 min were previously shown to display
several apoptotic-like features (11, 16). Both apoptotic-like
and aldehyde-fixed cells are effectively phagocytosed by mac-
rophages. Control macrophages did not receive lymphocyte
suspensions. Twenty-four hours later, cultures were washed
and infected with C. burnetii phase II bacteria and fixed at
different times after the infection. The percentage of macro-
phages that displayed LRVs was estimated as described in
Materials and Methods. Figure 1A shows that compared to
untreated or aldehyde-fixed cells, the uptake of apoptotic-like
lymphocytes significantly increased the formation of LRVs,
which is an essential step in the C. burnetii intracellular life
cycle (35).
Figure 1B shows a representative field of a PM culture
infected for 6 days with C. burnetii phase II: only one cell
presented the typical LRV, and another two cells were also
infected but controlled the LRV formation.
Although relative bacterial loads in LRVs did not change,
infective bacterial loads per well were increased in macro-
phage cultures that phagocytosed apoptotic cells. Relative
bacterial loads in LRVs were estimated by quantitative fluo-
rescence in digital images (DAPI-stained cells) obtained by
confocal microscopy as described in Materials and Methods.
Figure 2A shows that bacterium-associated fluorescence of
LRVs did not differ in control macrophage cultures when com-
pared to cultures that internalized apoptotic-like or aldehyde-
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fixed splenocytes. However, the overall infective bacterial
numbers recovered from macrophages that received apoptotic-
like splenocytes were significantly higher (Fig. 2B). It was pre-
viously shown that the LRVs are the main sites of C. burnetii
multiplication (33–35). This could explain why the uptake of
apoptotic-like cells increased the formation of LRVs (Fig. 1)
and the numbers of infective bacteria per culture well (Fig.
2B), although the bacterial load per LRV was similar in treated
and in untreated cultures (Fig. 2A).
Interpretation of the results presented so far requires infor-
mation on the relative uptake of the different splenocyte sus-
pensions by macrophage cultures. Figure 3 shows that the
phagocytic indices estimated in cultures fixed 3 h after addition
of splenocytes were similar for apoptotic-like or aldehyde-fixed
cells. The percentages of cells that phagocytosed heated, irra-
diated, or fixed splenocytes were, respectively, 41% 
 10%,
38% 
 3%, and 46% 
 13% (means 
 standard deviation).
The average number of splenocytes per cell in macrophages
that ingested heated, irradiated, or fixed splenocytes was 2.4 

0.8 (n  319), 2.5 
 0.4 (n  436), and 2.0 
 0.4 (n  348),
respectively. Thus, statistically significant differences were not
detected for either the phagocytic indices or the average num-
bers of particles taken up by the cells that phagocytosed.
Uptake of apoptotic-like cells reduces C. burnetii-induced
NO production by macrophages. It was previously shown that
infection with C. burnetii phase I or II induced NO production
by primary macrophages (32, 35). To investigate if uptake of
apoptotic-like cells affected the production of NO induced by
C. burnetii, we measured nitrite concentrations in cultures
treated or not with apoptotic-like or fixed splenocytes added to
the cultures 24 h prior to C. burnetii bacteria. Figure 4 shows
that C. burnetii-induced production of NO was reduced in
macrophages that phagocytosed apoptotic-like but not alde-
hyde-fixed splenocytes. NO production by the latter did not
differ from that of untreated cultures. These data are consis-
tent with previous observations reporting that uptake of apoptotic
cells down-regulates the NO production in macrophages stimu-
lated by gamma interferon and lipopolysaccharide (11, 12).
FIG. 1. Development of C. burnetii phase II LRVs in mouse PM that internalized apoptotic-like or aldehyde-fixed splenocytes. Splenocytes
were added at a multiplicity of three cells per macrophage. Twenty-four hours after treatment, cultures were infected with C. burnetii phase II, fixed
at different times, and processed as described in Materials and Methods. (A) Percentage of cells with LRVs as a function of the duration of
infection. Closed circles, cultures treated with apoptotic-like heated lymphocytes (Apoptosis); open circles, no addition of splenocytes to the
cultures (No addition); closed squares, cultures treated with fixed lymphocytes (Fixed). Asterisks indicate statistically significant differences
between the treatments (*, P 	 0.05; **, P 	 0.01). (B) Confocal images of a macrophage culture infected for 6 days with C. burnetii. DIC,
Nomarski differential interference contrast; DAPI, DNA fluorescence of the same field; MERGE, superimposed confocal images of DAPI
fluorescence (converted to black) and Nomarski DIC (gray). The arrow points to one cell with LRV. N, cell nuclei. Bar  10 m.
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Increased LRV formation in macrophages that have inter-
nalized apoptotic-like cells is NO dependent. The results de-
scribed above demonstrate that uptake of apoptotic-like cells
increased the development of LRVs in macrophages while it
diminished C. burnetii-induced NO production. We have pre-
viously found that the development of LRVs is increased by
AG, an inhibitor of iNOS, added to the macrophage cultures
together with the bacteria (35). To further examine the role of
NO in the increased formation of LRVs induced by the uptake
of apoptotic cells, we investigated the effects of apoptotic cells
and of AG when given singly or in combination to peritoneal or
bone marrow-derived macrophages 1 day prior to infection
with C. burnetii phase II bacteria. We have previously shown
that PM were more able to restrict LRV formation than
BMM (35). This difference is also evident in the results
shown in Table 1. However, the effects of the different treat-
ments were similar in both macrophage populations.
As previously described, AG or apoptotic-like cells (Apo-
heat)—but not fixed cells—given alone increased similarly the
percentage of cells that developed LRVs in peritoneal as well
as in BMM (Table 1). However, the effects of AG and of
apoptotic-like cells on the percentage of LRVs in peritoneal or
BMM were not additive, i.e., joint treatment with apoptotic-
like cells and AG did not significantly increase the formation of
LRVs compared to Apo-heat or AG alone (Table 1). These
results suggest that NO may play a role in LRV formation in
cultures treated by apoptotic cells. Table 1 also shows the
effects of the uptake of other particles in the control of LRV
formation by PM or BMM. For both PM and BMM,
statistically significant differences between untreated versus
treated cultures were found in the Apo-heat, Apo-irrad, AG,
and Apo-heat–plus–AG groups (Table 1).
To further examine the role of NO in the increased LRV
formation after uptake of apoptotic cells, we performed exper-
iments with macrophages from mice deficient in the iNOS
gene (iNOS/). As described in Fig. 1 and Table 1, wild-type
macrophages increased the frequency of LRVs when treated
FIG. 2. Relative intracellular load of C. burnetii phase II in mouse
PM cultures treated with apoptotic or aldehyde-fixed lymphocytes.
Twenty-four hours prior to C. burnetii infection, cultures were treated
with three apoptotic or fixed particles per macrophage; 6 days after
infection, cultures were fixed and processed as described in Materials
and Methods. (A) Relative intracellular load in the LRVs. (B) Infec-
tive bacterial load recovered from infected macrophages, with results
given as the relative infection index (FFU). Gray bars, untreated cul-
tures (No addition); black bars, treatment with apoptotic-like lympho-
cytes induced by heating (Apoptosis); open bars, treatment with fixed
lymphocytes (Fixed). Asterisks indicate statistically significant differ-
ences between the treatments (P 	 0.05).
FIG. 3. Uptake of splenocytes by PM. Cultures received spleno-
cytes that were either heat treated (Apo-heat), irradiated with 3,000
rads (Apo-irrad), or fixed at a multiplicity of three cells per macro-
phage and were fixed after 3 h. Phagocytic indices were determined as
described in Materials and Methods. Gray bars, Apo-heat; black bars,
Apo-irrad; open bars, fixed. Statistically significant differences were
not found between the treatments (P  0.05).
FIG. 4. Effect of splenocyte treatments on NO production induced
by C. burnetii infection. Twenty-four hours prior to C. burnetii infec-
tion, cultures received apoptotic-like (heat-treated) or aldehyde-fixed
splenocytes at a multiplicity of three cells per macrophage. Culture
supernatants were collected for nitrite determination 1 day after in-
fection as described in Materials and Methods. Gray bars, untreated
cultures (No addition); black bars, cultures treated with apoptotic-like
heated lymphocytes (Apoptosis); open bars, cultures treated with fixed
lymphocytes (Fixed). Asterisks indicate statistically significant differ-
ences between the treatments (P 	 0.05).
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with AG or heat-treated but not fixed splenocytes. In contrast,
macrophages from iNOS/ mice did not statistically differ
between the treatments (Fig. 5). It is of particular interest that,
in iNOS/ macrophages, the frequency of LRVs was in-
creased in all groups, i.e., in infected but otherwise untreated
controls and cultures treated with AG as well as in those that
phagocytosed apoptotic-like and fixed splenocytes (Fig. 5).
The increased bacterial load recovered from macrophage
cultures that internalized apoptotic-like cells was NO depen-
dent. We have shown that uptake of apoptotic cells increased
the frequency of LRVs in macrophages from wild-type but not
from iNOS/ mice (Fig. 5). If LRVs are the main sites of C.
burnetii multiplication, we should be able to recover higher
amounts of infective bacteria (focus-forming units [FFU])
from cultures that exhibit larger numbers of LRVs. Thus, we
performed an experiment similar to those shown in Fig. 5, but
instead of estimating the proportion of LRVs in cultures we
determined the relative loads of infective bacteria recovered
from the cultures as FFU (6, 22, 35). Figure 6 shows that
cultures treated with apoptotic splenocytes yielded more infec-
tive C. burnetii bacteria than untreated cultures or those
treated with fixed splenocytes. In contrast, similar amounts of
infective bacteria were recovered from iNOS/ macrophages
treated with either apoptotic or fixed splenocytes (Fig. 6). The
results shown in Fig. 5 and 6 strongly suggest that the uptake
of apoptotic-like splenocytes but not that of control particles
increased the susceptibility of primary macrophages to infec-
tion with C. burnetii phase II. Furthermore, the effect of apo-
ptotic lymphocytes, similar to that of the NO synthase inhibitor
AG, was mediated by down-regulation of the production of
NO by the phagocytes. Consistent with these data, it was re-
cently and independently shown that NO controls C. burnetii
phase II multiplication and the formation of LRVs (22, 35).
Due to the importance of the LRVs to C. burnetii pathogen-
esis, the control of their formation could be important in es-
tablishing the difference between resistance and susceptibility
to infection. However, mechanisms other than those involving
NO may also be involved in the control (35). Interestingly, the
amount of intracellular bacteria does not appear to affect the
formation of LRVs, since the infection of host cells with lower
or higher multiplicities of infection (30, 100, or 300 bacteria/
cell) did not affect the proportion of LRVs in murine macro-
phages (data not shown). Accordingly, Howe and his col-
FIG. 5. Effects of treatment with AG or apoptotic or fixed cells on
the formation of LRVs in PM from wild-type or iNOS-deficient mice
(iNOS/). Twenty-four hours prior to C. burnetii phase II infection,
cultures were treated with three apoptotic or fixed particles per mac-
rophage or with 1 mM AG. Six days after infection, cultures were fixed
and processed as described in Materials and Methods. Open bars,
untreated cultures (No addition); hatched bars, cultures treated with
AG; gray bars, cultures treated with apoptotic-like heated lymphocytes
(Apoptosis); black bars, cultures treated with fixed lymphocytes
(Fixed). Asterisks indicate statistically significant differences between
the treatments (P 	 0.05).
FIG. 6. Effect of treatment with apoptotic or fixed cells on the
infective bacterial load (FFU) recovered from PM from wild-type or
iNOS/ mice. Twenty-four hours prior to C. burnetii phase II infec-
tion, cultures were treated with three apoptotic or fixed splenocytes
per macrophage. Six days after infection, cultures were fixed and pro-
cessed as described in Materials and Methods. Open bars, untreated
cultures (No addition); hatched bars, cultures treated with apoptotic-
like heated lymphocytes (Apo-heat); gray bars, cultures treated with
apoptotic-like irradiated lymphocytes (Apo-irrad); black bars, cultures
treated with fixed lymphocytes (Fixed). Asterisks indicate statistically
significant differences between the treatments (P 	 0.05).
TABLE 1. Effect of uptake of different agents on infection of
BMM or PM with C. burnetii phase II
Host cell
treatmenta PM
b BMMb
No addition 8.0 
 0.4 11.1 
 1.2
Apo-heat 14.7 
 0.2** 33.4 
 7.4*
Apo-irrad 14.5 
 1.7* 20.6 
 2.5**
Fixed 9.2 
 1.3 15.1 
 5.8
Lysed 8.5 
 0.2 13.4 
 0.7
Live splenocytes 9.3 
 0.6 9.0 
 0.5
AG 13.8 
 0.2** 22.8 
 0.9*
Apo-heat  AG 15.2 
 0.9* 28.0 
 5.6*
a Macrophages were treated 24 h prior to infection with three particles per cell
or 1 mM AG.
b Percentage of cells (mean 
 standard error) containing LRVs 6 days after C.
burnetii infection. Significantly different result compared to control cells are
indicated with asterisks (*, P 	 0.05; **, P 	 0.01).
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leagues have recently demonstrated that only 10 infective C.
burnetii bacteria are sufficient to induce LRV formation in
Vero cells (23).
Future studies will be required to assess the pathways and
mechanisms by which the uptake of apoptotic cells down-mod-
ulates the production of NO. In this context, several studies
have revealed that phagocytosis of apoptotic cells inhibits the
production of IL-1, IL-8, IL-12, granulocyte-macrophage col-
ony-stimulating factor, and tumor necrosis factor alpha (8, 12,
24, 30). In contrast, the production of other mediators such as
TGF-, prostaglandin E2, and platelet-activating factor in-
creased (8, 11, 12, 24). It is possible that some of these cyto-
kines, singly or in combination, may account for the modula-
tion of NO production and therefore affect the intracellular
growth of C. burnetii.
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